Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Catalyst Pharmaceutical Partners Inc | 11 | 0 | 1 | 0 | €14.75 | €24.13 | 63.670% |
| Verastem Inc. | 10 | 0 | 2 | 0 | €4.02 | €24.63 | 512.806% |
| Xeris Biopharma Holdings Inc. | 5 | 0 | 1 | 0 | €1.80 | €4.16 | 131.178% |
| Abbott Laboratories | 17 | 0 | 1 | 0 | €95.51 | €116.71 | 22.200% |
| Vertex Pharmaceuticals Inc. | 47 | 2 | 7 | 0 | €424.50 | €425.79 | 0.303% |
| Novavax Inc. | 8 | 1 | 6 | 0 | €14.11 | €27.38 | 94.051% |
| Dynavax Technologies Corp | 2 | 0 | 1 | 0 | €10.96 | €26.95 | 145.891% |
| Cytokinetics Inc. | 31 | 1 | 8 | 0 | €44.60 | €83.13 | 86.393% |
| Halozyme Therapeutics Inc. | 15 | 0 | 3 | 0 | €40.40 | €47.17 | 16.757% |
| EyePoint Pharmaceuticals Inc. | 18 | 1 | 4 | 0 | €10.28 | €27.80 | 170.467% |
| Codexis Inc. | 5 | 2 | 1 | 0 | €3.23 | €8.36 | 158.675% |
| Agios Pharmaceuticals Inc. | 6 | 0 | 1 | 0 | €31.40 | €38.99 | 24.168% |
| Cara Therapeutics Inc. | 11 | 1 | 3 | 0 | €0.68 | €4.62 | 580.560% |
| Intra-Cellular Therapies Inc. | 25 | 0 | 2 | 0 | €60.50 | €79.55 | 31.495% |
| Akebia Therapeutics Inc. | 8 | 2 | 0 | 0 | €1.02 | €3.64 | 258.348% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 1 | 0 | €37.40 | €84.74 | 126.588% |
| Personalis Inc | 7 | 1 | 2 | 1 | €1.22 | €3.25 | 166.170% |
| Intellia Therapeutics Inc | 13 | 1 | 1 | 1 | €22.91 | €60.55 | 164.313% |
| Biogen Inc. | 49 | 1 | 7 | 1 | €201.00 | €293.57 | 46.056% |
| Insmed Inc. | 19 | 1 | 6 | 1 | €20.20 | €44.16 | 118.638% |
| Phibro Animal Health Corp. A | 4 | 2 | 0 | 1 | €16.90 | €12.06 | -28.615% |
| PTC Therapeutics Inc. | 15 | 7 | 3 | 2 | €33.80 | €41.81 | 23.710% |